Genistein upregulates cyclin D1 and CDK4 expression and promotes the proliferation of ovarian cancer OVCAR-5 cells

Yali Wang,Wen Li,Zhongwei Wang,Hongtao Ren,Yi Li,Yang Zhang,Pengtao Yang,Shupei Pan

DOI: https://doi.org/10.1016/j.cca.2019.08.023

IF: 6.314

2021-01-01

Clinica Chimica Acta

Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Ovarian epithelial cancer is the leading cause of deaths associated with gynecologic malignancies. Genistein represents a major type of phytoestrogens widely found in foods and herbal medicines. Although multiple epidemiological studies indicated that the consumption of genistein or other isoflavones is associated with a decreased ovarian cancer risk, the cellular effects and underlying mechanisms are not fully understood. This study focuses on the effect of genistein on the proliferation and cell cycle regulation of ovarian cancer cells.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Ovarian cancer OVCAR-5 cells were treated with genistein in an estrogen-free condition. Cell counting and MTS assays were performed to determine the cell proliferation alterations. Real-time PCR and Western blotting were conducted to examine the expression changes in key cell cycle regulators.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Genistein significantly promoted the proliferation and the viability of OVCAR-5 cells. Upon genistein treatment, cellular mRNA and protein expression levels of PCNA, Cyclin D1 and CDK4 were increased, but those of p21 and p27 were decreased.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>In contrary to results of many previous studies, we observed that genistein was able to upregulate the proliferation and G1-S transition of ovarian cancer OVCAR-5 cells. The discrepancy could be caused by diverged experimental conditions and/or different ER expression patterns of cell lines. The findings may provide basic information for in-depth analysis on the role(s) and mechanisms by which genistein confers its effect on ovarian cancer progression.</p>

medical laboratory technology

What problem does this paper attempt to address?

This paper attempts to explore the effect of genistein, one of the soy isoflavone components, on the proliferation of ovarian cancer cell line OVCAR - 5 and its potential mechanisms. Although many epidemiological studies have shown that the intake of soy isoflavones or similar substances is related to the reduction of ovarian cancer risk, their specific cellular effects and action mechanisms are not yet fully understood. In this paper, by treating OVCAR - 5 cells under estrogen - free conditions, cell counting and MTS assays were used to evaluate the changes in cell proliferation, and the expression changes of key cell - cycle regulatory factors were analyzed by real - time PCR and Western blot to explore the specific effects of genistein on the proliferation of ovarian cancer cells. The study found that genistein can significantly promote the proliferation and survival rate of OVCAR - 5 cells, and up - regulate the mRNA and protein expression levels of PCNA, Cyclin D1 and CDK4, while down - regulating the expression of p21 and p27. These results suggest that under specific conditions, genistein may enhance the proliferation ability of ovarian cancer cells by promoting the G1 - S phase transition. This finding provides basic information for in - depth understanding of the role of genistein in the progression of ovarian cancer.